Figure1 .
RAP2 predicts unfavorable prognosis of pancreatic cancer
(A) Immunohistochemical analysis for the tissue RAP2 expression in the FUSCC cohort at high magnification (400×). Scale bar=50 μm (black line at the bottom right). (B) The expression of RAP2 in pancreatic cancer and para-carcinoma tissue. (C) High level of tissue RAP2 expression predicts a poor prognosis to pancreatic cancer in the FUSCC cohort.